184 related articles for article (PubMed ID: 30848689)
21. A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity.
Peng LS; Penichet ML; Morrison SL
J Immunol; 1999 Jul; 163(1):250-8. PubMed ID: 10384123
[TBL] [Abstract][Full Text] [Related]
22. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
[TBL] [Abstract][Full Text] [Related]
23. IL4-10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10.
Steen-Louws C; Hartgring SAY; Popov-Celeketic J; Lopes AP; de Smet MBM; Eijkelkamp N; Lafeber FPJG; Hack CE; van Roon JAG
Clin Exp Immunol; 2019 Jan; 195(1):1-9. PubMed ID: 30307604
[TBL] [Abstract][Full Text] [Related]
24. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.
Wang M; Fudge K; Rhim JS; Stearns ME
Oncol Res; 1996; 8(7-8):303-15. PubMed ID: 8938794
[TBL] [Abstract][Full Text] [Related]
25. MICA/IL-12: A novel bifunctional protein for killer cell activation.
Tietje A; Yang X; Yu X; Wei Y
Oncol Rep; 2017 Mar; 37(3):1889-1895. PubMed ID: 28098874
[TBL] [Abstract][Full Text] [Related]
26. Enhancing Lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury.
Monteleone G; MacDonald TT; Wathen NC; Pallone F; Pender SL
Gastroenterology; 1999 Nov; 117(5):1069-77. PubMed ID: 10535869
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-1 and tumor necrosis factor-alpha induce collagenolysis and bone resorption by regulation of matrix metalloproteinase-2 in mouse calvarial bone cells.
Kang BS; Park YG; Cho JY; Kim JK; Lee TK; Kim DW; Gu YH; Suzuki I; Chang YC; Kim CH
Immunopharmacol Immunotoxicol; 2003 Aug; 25(3):347-64. PubMed ID: 19180798
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke.
Kouwenhoven M; Carlström C; Ozenci V; Link H
J Clin Immunol; 2001 Sep; 21(5):365-75. PubMed ID: 11720009
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of antitumor immune response by targeted interleukin-12 electrogene transfer through antiHER2 single-chain antibody in a murine bladder tumor model.
Tsai YS; Shiau AL; Chen YF; Tsai HT; Lee HL; Tzai TS; Wu CL
Vaccine; 2009 Aug; 27(39):5383-92. PubMed ID: 19596413
[TBL] [Abstract][Full Text] [Related]
30. Expression of matrix metalloproteinase-2 and -9 in human ligamentum flavum cells treated with tumor necrosis factor-α and interleukin-1β.
Kim BJ; Hur JW; Park JS; Kim JH; Kwon TH; Park YK; Moon HJ
J Neurosurg Spine; 2016 Mar; 24(3):428-35. PubMed ID: 26565765
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-12-mediated expression of matrix metalloproteinases in human periodontal ligament fibroblasts involves in NF-κB activation.
Miao L; Zhan S; Liu J
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054963
[TBL] [Abstract][Full Text] [Related]
32. Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.
Kan F; Ren G; Guo M; Qi J; Zhang Y; Han Y; Zhang Y; Li D
Curr Pharm Biotechnol; 2014; 14(12):1048-61. PubMed ID: 24433504
[TBL] [Abstract][Full Text] [Related]
33. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.
Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T
Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528
[TBL] [Abstract][Full Text] [Related]
34. Spirulina lipopolysaccharides inhibit tumor growth in a Toll-like receptor 4-dependent manner by altering the cytokine milieu from interleukin-17/interleukin-23 to interferon-γ.
Okuyama H; Tominaga A; Fukuoka S; Taguchi T; Kusumoto Y; Ono S
Oncol Rep; 2017 Feb; 37(2):684-694. PubMed ID: 28075473
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of the antiangiogenic activity of interleukin-12 by peptide targeted delivery of the cytokine to alphavbeta3 integrin.
Dickerson EB; Akhtar N; Steinberg H; Wang ZY; Lindstrom MJ; Padilla ML; Auerbach R; Helfand SC
Mol Cancer Res; 2004 Dec; 2(12):663-73. PubMed ID: 15634755
[TBL] [Abstract][Full Text] [Related]
36. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
[TBL] [Abstract][Full Text] [Related]
38. Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin.
Liu S; Netzel-Arnett S; Birkedal-Hansen H; Leppla SH
Cancer Res; 2000 Nov; 60(21):6061-7. PubMed ID: 11085528
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms involved in enhancement of matrix metalloproteinase-9 expression in macrophages by interleukin-33.
Ariyoshi W; Okinaga T; Chaweewannakorn W; Akifusa S; Nisihara T
J Cell Physiol; 2017 Dec; 232(12):3481-3495. PubMed ID: 28105703
[TBL] [Abstract][Full Text] [Related]
40. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
